David J. Wambeke, Chief Business Officer at NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC), bought 33,333 shares at $2.01 ($67K) on 2026-08-27, disclosed to the SEC on 2026-09-08.
Open-market purchase of $67k NMTC by Chief Business Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| DMAC | BUY | 2023-06-26 | $300K | — | Filing → |
| DMAC | BUY | 2023-04-11 | $750K | — | Filing → |